In May 2017, another class-action lawsuit was filed against Gerber for allegedly falsely marketing Good Start Gentle infant formula made from partially hydrolyzed whey protein as:
- Reducing the risk of infants developing allergies and infant atopic dermatitis (commonly known as eczema) when, according to plaintiffs, scientific studies have concluded that partially hydrolyzed whey formula does not lower the risk of developing allergies and eczema when compared to conventional formula;
- The “first and only” formula endorsed by the FDA to reduce the risk of developing allergies when, according to the complaint, such claims are not true;
- Having received FDA approval for health claims using the term “Qualified Health Claim” when, according to plaintiffs, the FDA has not approved the health claims and the claims do not have adequate scientific support.
(Hobbs et al v. Gerber Products Co. d/b/a Nestle Nutrition et al, Case No. 17-cv-3534, N. D. IL.)
For more information about other class-action lawsuits filed against Gerber and TINA.org’s coverage of the company, click here.